|
|
||||||||
1 Physiology Program, Harvard School of Public Health, Boston 02115; and 2 Department of Medicine, Harvard Medical School, West Roxbury Brockton Veterans Affairs Medical Center, Boston, Massachusetts 02132
| |
ABSTRACT |
|---|
|
|
|---|
The device described in this study uses functionally variable dead space to keep effective alveolar ventilation constant. It is capable of maintaining end-tidal PCO2 and PO2 within ±1 Torr of the set value in the face of increases in breathing above the baseline level. The set level of end-tidal PCO2 or PO2 can be independently varied by altering the concentration in fresh gas flow. The device comprises a tee at the mouthpiece, with one inlet providing a limited supply of fresh gas flow and the other providing reinspired alveolar gas when ventilation exceeds fresh gas flow. Because the device does not depend on measurement and correction of end-tidal or arterial gas levels, the response of the device is essentially instantaneous, avoiding the instability of negative feedback systems having significant delay. This contrivance provides a simple means of holding arterial blood gases constant in the face of spontaneous changes in breathing (above a minimum alveolar ventilation), which is useful in respiratory experiments, as well as in functional brain imaging where blood gas changes can confound interpretation by influencing cerebral blood flow.
hypercapnia; alveolar ventilation; brain imaging; functional magnetic response imaging; positron emission tomography
| |
INTRODUCTION |
|---|
|
|
|---|
THE DESIGN PRESENTED IS A convenient way to keep end-tidal PCO2 (PETCO2) and PO2 constant, even in the case of rapidly changing ventilation. Such a device is useful in several experimental circumstances, for instance when it is desired to have subjects voluntarily increase respiratory frequency (f) or tidal volume (VT) to examine perceptual consequences (e.g., Ref. 4) or to test respiratory muscle performance (e.g., Ref. 2). In other circumstances, breathing may change spontaneously (e.g., because of anxiety) and can cause undesirable secondary effects, which confound interpretation of the experiment. A prime example of this is found in modern techniques for functional brain imaging. Positron emission tomography and functional magnetic resonance imaging are techniques to measure local cerebral metabolism, thus inferring neural activity. Both techniques depend on changes in cerebral blood flow (1), which is strongly influenced by arterial PCO2 (3). This contrivance also makes it convenient to measure steady-state ventilatory response to CO2, as the desired CO2 level is more easily maintained in the face of consequent changes in ventilation.
Sommer et al. (6) recently described a device that reduces changes in alveolar gases during hyperpnea. Our device, like theirs, limits the amount of fresh gas inspired and supplies additional gas containing higher PCO2 and lower PO2 for any additional ventilation. The Sommer et al. device, however, supplies additional gas from a tank containing an approximation of "average" alveolar gas composition, whereas our device supplies the actual alveolar gas expired on the previous breath, thus providing somewhat more precise regulation. Our device not only automatically adjusts for small (±10%) differences in resting PETCO2 or end-tidal PO2 among subjects but also allows us to make intentional large changes in PCO2 (or PO2) and hold each new level constant.
| |
METHODS |
|---|
|
|
|---|
Overview. The subject expires into a large tube that serves as an alveolar gas reservoir. Inspiratory gas initially comes from a bag reservoir supplied by a high-impedance constant-flow source. As the subject continues inspiration after the fresh gas from the bag has been exhausted, pressure drops in the system, and a spring-loaded valve at the distal end of the alveolar gas reservoir opens. The subject is thus able to breathe in more gas, but its composition is identical to alveolar gas. The minimum alveolar ventilation at which this device will hold constant PCO2 is the alveolar ventilation, which establishes PCO2 with no inspired CO2.
Contrivance design.
The contrivance, depicted in Fig. 1,
comprises a manifold (T piece) connected to two tubes and a mouthpiece
(or tightly sealed mask). One tube, the fresh gas inspiratory limb,
provides gas from a 3-liter anesthetic bag via a one-way valve and a
1-m-long by 3.8-cm-ID tube. Fresh gas from a high-impedance flow (e.g., compressed gas tanks) is continuously fed to the anesthetic bag via a
flowmeter; the flow through this meter determines the amount of
inspired fresh gas or effective alveolar ventilation.
The resistance of the line from bag to mouthpiece should be as low as
possible. Depending on the requirements of the experiment, the fresh
gas can be air, oxygen, or some other oxygen-containing blend to suit the requirements of the experiment (see Varying gas
concentration below). In our laboratory, inspired fresh gas is
heated and humidified (SCT 3000 Marquest Medical Products), and
expiratory tubing is insulated to minimize cooling and condensation.
|
7.5 cmH2O). Figure
2 shows the flow vs. pressure curves for
various opening settings on this valve. The pressure-flow characteristics were determined by employing a flow source (Lewyt vacuum cleaner model 59) connected to the breathing device at the
mouthpiece. Pressure was sampled at the mouth end of the valve, referred to atmospheric pressure.
|
Operation of the system. Before the subject is connected to the mouthpiece, a normal resting PETCO2 is measured with a fine nasal cannula while the subject sits quietly (5). It is our experience that subjects almost invariably increase ventilation behaviorally when breathing via a mouthpiece or mask. Thus to achieve normal resting PETCO2 it is necessary to impose some rebreathing, even in the baseline state. After the subject is connected to the mouthpiece, the flow of fresh gas into the anesthetic bag is adjusted such that during baseline there is a small amount of alveolar gas reinspired from the expiratory limb. This should be confirmed both by visual verification that the bag fully collapses and by inspection of the tidal PCO2 or PO2 trace to confirm slight reinspiration of alveolar gas. Because baseline ventilation in the mouthpiece requires some reinspiration to achieve resting PETCO2, the system can maintain constant alveolar concentrations in the face of small decreases in ventilation, as well as large increases in ventilation.
Varying gas concentration. For some experiments, it is desirable to vary alveolar gas concentration. This is easily accomplished by altering the content of the fresh gas supply. We find it convenient to use a gas blender to supply fresh gas (e.g., Siemens model 965). For instance, in an experiment requiring constant normoxia and variable PETCO2, one could blend from a gas cylinder containing 21% O2-balance N2 and a tank containing 15% CO2-21% O2-balance N2. The most rapid rise in PETCO2 is accomplished by giving a few breaths of high inspired PCO2 (PICO2) and then gradually reducing the inspired concentration to the required steady-state level. (In perceptual experiments, we generally avoid PICO2 greater than PETCO2 to minimize possible taste cues.) The most rapid fall in PETCO2 requires not only reducing PICO2 to zero but also temporarily increasing fresh gas flow. In experiments not requiring this speed and precision, inspired gas flow could simply be switched between two fixed concentrations.
Safety precautions. It is standard practice in our laboratory never to connect any gas supply to the breathing apparatus that does not contain adequate oxygen to support life. It is also routine to monitor arterial saturation with a pulse oximeter whenever a subject is connected to any breathing circuit.
Test of efficacy. We tested the system's ability to maintain constant PETCO2 by instructing subjects to target breathing to a metronome at various frequencies while they were being coached to breathe at particular VT values. This provided a range of ventilations from 5 to 60 l/min achieved with eight different combinations of VT and f by using VT values of 0.5-3 liters and f values of 10-40 breaths/min. Transitions between patterns of ventilation were made within a few breaths, and each new pattern was held for 3 min during which PETCO2 was monitored for deviations from the set level.
Measurements and recordings.
Subjects breathed via the mouthpiece and wore a nose clip. Tidal
PCO2 and
PO2 were monitored continuously (Datex-Engstrom Cardio Cap II). Flow was sampled at the mouth and at
the rebreathing control valve (Fleisch Pneumotachograph no. 2. and
Validyne MP45 with 2-cmH2O diaphragm). Airway opening pressure was measured at the mouthpiece (Validyne MP45 with
56-cmH2O diaphragm). Analog signals were digitized at a
sample rate of 20 samples · s
1 · channel
1
and recorded by using data-acquisition software (Windaq/200, DATAQ
Instruments, Akron, OH).
| |
RESULTS AND DISCUSSION |
|---|
|
|
|---|
Efficacy.
Fig. 3 shows pertinent pressures, flows,
and tidal gases during a range of conditions of VT and f
voluntarily achieved by one subject. In steady-state conditions, the
system was capable of maintaining
PETCO2 within ±2 Torr of
baseline in the worst case of five subjects tested, and ±1 Torr was
the typical performance. We also examined performance when the system
was challenged by two- to fivefold rapid transitions between levels of
ventilation. We used as a measure of performance the variability of
PETCO2 during the 20 breaths
surrounding transitions. The worst case showed a standard deviation of
1 Torr, and the best, 0.2 Torr. Median standard deviation of 25 transitions was 0.5 Torr. Typical transitions are shown in Fig.
4. Our measurements show improved precision
of PETCO2 regulation over
those of Sommer et al. (6), but we do not know whether operation of
their system could be further improved.
|
|
Limitations. This device is relatively insensitive to changes in VT and f, because most of the fresh gas is inspired first; however, neither the present device nor that of Sommer et al. (6) can prevent a rise in PETCO2 if the subject reduces real alveolar ventilation below minimum alveolar ventilation. This may occur if the subject reduces minute ventilation, or if the subject adopts a breathing pattern of very small VT with high f, so that much of the fresh gas penetrates no further than the anatomic dead space. Whereas this pattern of breathing is unphysiological in humans, it implies that the device will not work in animals that pant (although the problem should be ameliorated by the effects of high-f mixing). Furthermore, these devices do not automatically adapt to changes in metabolic CO2 production.
Subjects did detect a slight added resistance to breathing, as would be predicted from psychophysical data (7). Many subjects could detect the change in pressure as the bag collapsed and the rebreathing control valve opened. We were able to keep inspiratory pressure drops below a level objectionable to most subjects. This required careful attention to the minimization of impedance in the fresh gas limb so that the rebreathing control valve threshold could be set to <2 cmH2O, typically 1 cmH2O. If necessary for a particular experiment, the impedance of both limbs of the device could be reduced further.Troubleshooting common problems. This system has been in use in our laboratory for 2 yr. We encountered several problems while setting up and learning to use this device. Most problems result in a fall in PETCO2 at high ventilation. Possible causes are as follows. 1) VT in large subjects may exceed the volume of the expired gas reservoir; this is easily remedied by extending the length of the reservoir tube. 2) Inward leaks (especially when a face mask is used) compromise operation by allowing added fresh gas into the system. 3) The threshold valve may open prematurely because of a) valve malfunction or b) excessive resistance in the fresh gas line, which causes the pressure drop to exceed threshold before the bag collapses. This malfunction can be detected by setting fresh air flow just above minute ventilation (so the bag does not fully collapse) and observing whether PCO2 remains zero throughout inspiration. 4) There is excessive fresh gas flow at baseline.
Another common problem is excessive pressure drop or pressure fluctuation during inspiration (usually brought to our attention by the subject). Possible causes are as follows: 1) sticky valves; 2) high resistance of inspiratory limb requiring a high opening pressure setting for rebreathing control valve; and 3) excessive mass of rebreathing control valve flapper can create a resonant system interacting with the inertance or compliance of the gas in the alveolar reservoir. We first tried rebreathing control valves with weight thresholds and found them unsuitable for this reason.Conclusion. The contrivance presented here is simple to implement, provides somewhat more precise regulation of end-tidal gases than previous designs, and conveniently allows one end-tidal gas to be independently varied.
| |
ACKNOWLEDGEMENTS |
|---|
We thank our subjects for their time and cooperation and George Emerson of J. H. Emerson Company for designing and constructing a prototype valve to meet our specifications.
| |
FOOTNOTES |
|---|
This study was supported by National Heart, Lung, and Blood Institute Grant HL-46690.
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: R. B. Banzett, Physiology Program, Dept. of Environmental Health, Harvard School of Public Health, 665 Huntington Ave., Boston, MA 02115-6021.
Received 27 December 1999; accepted in final form 3 January 2000.
| |
REFERENCES |
|---|
|
|
|---|
1.
Kwong, KK,
Belliveau JW,
Chesler DA,
Goldberg IE,
Weisskoff RM,
Poncelet BP,
Kennedy DN,
Hoppel BE,
Cohen MS,
and
Turner R.
Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation.
Proc Natl Acad Sci USA
89:
5675-5679,
1992
2.
Leith, D,
and
Bradley M.
Ventilatory muscle strength and endurance training.
J Appl Physiol
41:
508-516,
1976
3.
Ramsay, SC,
Murphy K,
Shea SA,
Friston KJ,
Lammertsma AA,
Clark JC,
Adams L,
Guz A,
and
Frackowiak RS.
Changes in global cerebral blood flow in humans: effect on regional cerebral blood flow during a neural activation task.
J Physiol (Lond)
471:
521-534,
1993
4.
Remmers, JE,
Brooks J,
and
Tenney SM.
Effect of controlled ventilation on the tolerable limit of hypercapnia.
Respir Physiol
4:
78-90,
1968[ISI][Medline].
5.
Shea, SA,
Walter J,
Murphy K,
and
Guz A.
Evidence for individuality of breathing patterns in resting healthy man.
Respir Physiol
68:
331-344,
1987[ISI][Medline].
6.
Sommer, LZ,
Iscoe S,
Robicsek A,
Kruger J,
Silverman J,
Rucker J,
Dickstein J,
Volgyesi GA,
and
Fisher JA.
A simple breathing circuit minimizing changes in alveolar ventilation during hyperpnoea.
Eur Respir J
12:
698-701,
1998[Abstract].
7.
Zechman, FW, Jr,
and
Wiley RL.
Afferent inputs to breathing: respiratory sensation.
In: Handbook of Physiology. The Respiratory System. Control of Breathing. Bethesda, MD: Am. Physiol. Soc, 1986, sect. 3, vol. II, pt. 1, chapt. 14, p. 449-474.
This article has been cited by other articles:
![]() |
B. W. Wilkins, T. L. Pike, E. A. Martin, T. B. Curry, M. L. Ceridon, and M. J. Joyner Exercise intensity-dependent contribution of {beta}-adrenergic receptor-mediated vasodilatation in hypoxic humans J. Physiol., February 15, 2008; 586(4): 1195 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Simmons, J. M. Manson, and J. R. Halliwill Mild central chemoreflex activation does not alter arterial baroreflex function in healthy humans J. Physiol., September 15, 2007; 583(3): 1155 - 1163. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Simmons, C. T. Minson, J.-L. Cracowski, and J. R. Halliwill Systemic hypoxia causes cutaneous vasodilation in healthy humans J Appl Physiol, August 1, 2007; 103(2): 608 - 615. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Slessarev, J. Han, A. Mardimae, E. Prisman, D. Preiss, G. Volgyesi, C. Ansel, J. Duffin, and J. A. Fisher Prospective targeting and control of end-tidal CO2 and O2 concentrations J. Physiol., June 15, 2007; 581(3): 1207 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. W. Wilkins, W. G. Schrage, Z. Liu, K. C. Hancock, and M. J. Joyner Systemic hypoxia and vasoconstrictor responsiveness in exercising human muscle J Appl Physiol, November 1, 2006; 101(5): 1343 - 1350. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Meadows, F. Kotajima, A. Vazir, K. Kostikas, A. K. Simonds, M. J. Morrell, and D. R. Corfield Overnight Changes in the Cerebral Vascular Response to Isocapnic Hypoxia and Hypercapnia in Healthy Humans: Protection Against Stroke Stroke, November 1, 2005; 36(11): 2367 - 2372. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Iscoe and J. A. Fisher Hyperoxia-Induced Hypocapnia: An Underappreciated Risk Chest, July 1, 2005; 128(1): 430 - 433. [Full Text] [PDF] |
||||
![]() |
S. H. Moosavi, R. B. Banzett, and J. P. Butler Time course of air hunger mirrors the biphasic ventilatory response to hypoxia J Appl Physiol, December 1, 2004; 97(6): 2098 - 2103. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Meadows, D. M. O'Driscoll, A. K. Simonds, M. J. Morrell, and D. R. Corfield Cerebral blood flow response to isocapnic hypoxia during slow-wave sleep and wakefulness J Appl Physiol, October 1, 2004; 97(4): 1343 - 1348. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Gilmore, C. Hudson, S. T. Venkataraman, D. Preiss, and J. Fisher Comparison of Different Hyperoxic Paradigms to Induce Vasoconstriction: Implications for the Investigation of Retinal Vascular Reactivity Invest. Ophthalmol. Vis. Sci., September 1, 2004; 45(9): 3207 - 3212. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Weisbrod, P. R. Eastwood, G. O'Driscoll, J. H. Walsh, M. Best, J. R. Halliwill, and D. J. Green Vasomotor Responses to Hypoxia in Type 2 Diabetes Diabetes, August 1, 2004; 53(8): 2073 - 2078. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. O'Driscoll, G. E. Meadows, D. R. Corfield, A. K. Simonds, and M. J. Morrell Cardiovascular response to arousal from sleep under controlled conditions of central and peripheral chemoreceptor stimulation in humans J Appl Physiol, March 1, 2004; 96(3): 865 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. McKay, K. C. Evans, R. S. J. Frackowiak, and D. R. Corfield Neural correlates of voluntary breathing in humans J Appl Physiol, September 1, 2003; 95(3): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Moosavi, E. Golestanian, A. P. Binks, R. W. Lansing, R. Brown, and R. B. Banzett Hypoxic and hypercapnic drives to breathe generate equivalent levels of air hunger in humans J Appl Physiol, January 1, 2003; 94(1): 141 - 154. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. LANSING, B. S.-H. IM, J. I. THWING, A. T. R. LEGEDZA, and R. B. BANZETT The Perception of Respiratory Work and Effort Can Be Independent of the Perception of Air Hunger Am. J. Respir. Crit. Care Med., November 1, 2000; 162(5): 1690 - 1696. [Abstract] [Full Text] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |